81 Publications (Page 2 of 4)
Pharmacokinetics of intravenous voriconazole in obese patients: implications of CYP2C19 homozygous poor metabolizer genotype.
Moriyama, BradJarosinski, Paul FFigg, William DHenning, Stacey ADanner, Robert LPenzak, Scott RWayne, Alan S and Walsh, Thomas J
Pharmacotherapy, vol. 33, (no. 3), pp. e19-22, 2013/Mar. | Journal Article
The effect of antiretrovirals on Plasmodium falciparum liver stages.
Hobbs, CharlotteHobbs, Charlotte VDe La Vega, PatriciaDe La Vega, PatriciaPenzak, Scott RPenzak, Scott RVan Vliet, JillianVan Vliet, JillianKrzych, UrszulaKrzych, UrszulaSinnis, PhotiniSinnis, PhotiniBorkowsky, WilliamBorkowsky, WilliamDuffy, Patrick E and Duffy, Patrick E
AIDS (London, England), vol. 27, (no. 10), pp. 1674-7, 2013/Jun/19. | Journal Article
Adverse interactions between antifungal azoles and vincristine: review and analysis of cases.
Moriyama, BradHenning, Stacey ALeung, JaniceFalade-Nwulia, OluwaseunJarosinski, PaulPenzak, Scott R and Walsh, Thomas J
Mycoses, vol. 55, (no. 4), pp. 290-297, July 2012. | Journal Article
HIV nonnucleoside reverse transcriptase inhibitors and trimethoprim-sulfamethoxazole inhibit plasmodium liver stages.
Hobbs, CharlotteVoza, TatianaDe La Vega, PatriciaVanvliet, JillianConteh, SolomonPenzak, Scott RFay, Michael PAnders, NicoleIlmet, TiinaLi, YonghuaBorkowsky, WilliamKrzych, UrszulaDuffy, Patrick E and Sinnis, Photini
The Journal of infectious diseases, vol. 206, (no. 11), pp. 1706-14, 2012/Dec/1. | Journal Article
Impaired maraviroc and raltegravir clearance in a human immunodeficiency virus-infected patient with end-stage liver disease and renal impairment: a management dilemma.
Pau, Alice KPenzak, Scott RBoyd, Sarita DMcLaughlin, Mary and Morse, Caryn G
Pharmacotherapy, vol. 32, (no. 1), pp. e1-e6, January 2012. | Journal Article
Influence of panax ginseng on cytochrome P450 (CYP)3A and p-glycoprotein
Robertson, SarahHunt, JenniferChairez, CherylAlfaro, RaulPenzak, ScottMalati, Christine and Kovacs, Joseph
Journal of Clinical Pharmacology, vol. 52, (no. 6), pp. 932, 20120601. | Journal Article
Influence of Panax ginseng on cytochrome P450 (CYP)3A and P-glycoprotein (P-gp) activity in healthy participants.
Malati, Christine YRobertson, Sarah MHunt, Jennifer DChairez, CherylAlfaro, Raul MKovacs, Joseph A and Penzak, Scott R
Journal of clinical pharmacology, vol. 52, (no. 6), pp. 932-939, June 2012. | Journal Article
Lack of a pharmacokinetic drug-drug interaction with venlafaxine extended-release/indinavir and desvenlafaxine extended-release/indinavir
Jann, MichaelSpratlin, VickyMomary, KathrynZhang, HailingTurner, DavidPenzak, ScottWright, Alan and Vandenberg, Chad
European Journal of Clinical Pharmacology, vol. 68, (no. 5), pp. 715-21, May 2012. | Journal Article
Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV.
Musselwhite, Laura WSheikh, VirginiaNorton, Thomas DRupert, AdamPorter, Brian OPenzak, Scott RSkinner, JeffMican, JoAnn MHadigan, Colleen and Sereti, Irini
AIDS (London, England), vol. 25, (no. 6), pp. 787-795, March 27, 2011. | Journal Article
Pharmacokinetics of anidulafungin in pleural fluid during the treatment of a patient with Candida empyema.
Moriyama, BradDitullio, MarisaWilson, EleanorHenning, Stacey APenzak, Scott RDanner, Robert LPennick, GennethelRinaldi, Michael GZelazny, Adrian MGea-Banacloche, JuanBarrett, A J and Walsh, Thomas J
Antimicrobial agents and chemotherapy, vol. 55, (no. 5), pp. 2478-80, 2011/May. | Journal Article
Prolonged half-life of voriconazole in a CYP2C19 homozygous poor metabolizer receiving vincristine chemotherapy: avoiding a serious adverse drug interaction.
Moriyama, BradFalade-Nwulia, OluwaseunLeung, JanicePenzak, Scott RJJingo, CarolineHuang, XuanHenning, Stacey AWilson, Wyndham H and Walsh, Thomas J
Mycoses, vol. 54, (no. 6), pp. e877-e879, November 2011. | Journal Article
The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome.
McDermott, David HLiu, QianUlrick, JeanKwatemaa, NanaAnaya-O'Brien, SandraPenzak, Scott RFilho, Joao OPriel, Debra AKelly, CorinGarofalo, MaryLittel, PatriciaMarquesen, Martha MHilligoss, DianeDecastro, RosammaFleisher, Thomas AKuhns, Douglas BMalech, Harry L and Murphy, Philip M
Blood, vol. 118, (no. 18), pp. 4957-62, 2011/Nov/3. | Journal Article
Assessment of oral midazolam limited sampling strategies to predict area under the concentration time curve (AUC) during cytochrome P450 (CYP) 3A baseline, inhibition and induction or activation.
Ma, Joseph DNguyen, E TTsunoda, S MGreenberg, H EGorski, J CPenzak, S R and Lee, L S
International journal of clinical pharmacology and therapeutics, vol. 48, (no. 12), pp. 847-53, 2010/Dec. | Journal Article
Echinacea purpurea significantly induces cytochrome P450 3A activity but does not alter lopinavir-ritonavir exposure in healthy subjects.
Penzak, Scott RRobertson, Sarah MHunt, Jennifer DChairez, CherylMalati, Christine YAlfaro, Raul MStevenson, James M and Kovacs, Joseph A
Pharmacotherapy, vol. 30, (no. 8), pp. 797-805, August 2010. | Journal Article
The pharmacodynamic equivalence of levothyroxine and liothyronine: a randomized, double blind, cross-over study in thyroidectomized patients.
Celi, Francesco SaverioZemskova, MarinaLinderman, Joyce DBabar, Nabeel ISkarulis, Monica CCsako, GyorgyWesley, RobertCostello, RenePenzak, Scott R and Pucino, Frank
Clinical endocrinology, vol. 72, (no. 5), pp. 709-15, 2010/May. | Journal Article
Gemfibrozil concentrations are significantly decreased in the presence of lopinavir-ritonavir.
Busse, Kristin HHadigan, ColleenChairez, CherylAlfaro, Raul MFormentini, ElizabethKovacs, Joseph A and Penzak, Scott R
Journal of acquired immune deficiency syndromes (1999), vol. 52, (no. 2), pp. 235-239, October 1, 2009. | Journal Article
Pharmacology and Antifungal Properties of Anidulafungin, a New Echinocandin
Estes, Kristina EPenzak, Scott RCalis, Karim Anton and Walsh, Thomas J
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, vol. 29, (no. 1), pp. 30, January 2009. | Journal Article
Effect of Ginkgo biloba extract on lopinavir, midazolam and fexofenadine pharmacokinetics in healthy subjects.
Robertson, Sarah MDavey, Richard TVoell, JocelynFormentini, ElizabethAlfaro, Raul M and Penzak, Scott R
Current medical research and opinion, vol. 24, (no. 2), pp. 591-599, February 2008. | Journal Article
Examining sex-related differences in enteric itraconazole metabolism in healthy adults using grapefruit juice
Gubbins, PaulGurley, BillWilliams, DavidPenzak, ScottMcConnell, ScottFranks, Amy and Saccente, Michael
European Journal of Clinical Pharmacology, vol. 64, (no. 3), pp. 293-301, Mar 2008. | Journal Article
Influence of antiretroviral drugs on the pharmacokinetics of prednisolone in HIV-infected individuals.
Busse, Kristin HFormentini, ElizabethAlfaro, Raul MKovacs, Joseph A and Penzak, Scott R
Journal of acquired immune deficiency syndromes (1999), vol. 48, (no. 5), pp. 561-566, August 15, 2008. | Journal Article
Limitations of using a single postdose midazolam concentration to predict CYP3A-mediated drug interactions.
Penzak, Scott RBusse, Kristin HRobertson, Sarah MFormentini, ElizabethAlfaro, Raul M and Davey, Richard T
Journal of clinical pharmacology, vol. 48, (no. 6), pp. 671-680, June 2008. | Journal Article
Pharmacokinetics and tolerability of oseltamivir combined with probenecid.
Holodniy, MarkPenzak, Scott RStraight, Timothy MDavey, Richard TLee, Kelvin KGoetz, Matthew BRaisch, Dennis WCunningham, FrancescaLin, EmilOlivo, Noemi and Deyton, Lawrence R
Antimicrobial agents and chemotherapy, vol. 52, (no. 9), pp. 3013-21, 2008/Sep. | Journal Article
Pharmacokinetics of Low and Maintenance Dose Valganciclovir in Kidney Transplant Recipients
Chamberlain, CEPenzak, S. RAlfaro, RMWesley, R.Daniels, CEHale, DavidKirk, Allan D and Mannon, Roslyn
American Journal of Transplantation, vol. 8, (no. 6), pp. 1297-1302, 2008. | Journal Article
Pharmacological enhancement of protease inhibitors with ritonavir: an update
Busse, Kristin H and Penzak, Scott R
Expert Review of Clinical Pharmacology, vol. 1, (no. 4), pp. 545, 7/1/2008. | Journal Article
Darunavir: a second-generation protease inhibitor.
Busse, Kristin H S and Penzak, Scott R
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, vol. 64, (no. 15), pp. 1593-1602, August 1, 2007. | Journal Article